Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

COAGHemab Therapeutics Holdings, Inc.

Nasdaq · CIK 0002114044
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts113

Identity from submissions API

NameHemab Therapeutics Holdings, Inc.
CIK0002114044
TickersCOAG
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN414241952
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone45 2138 7627
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
101 MAIN STREET
SUITE 1220
CAMBRIDGE
MA
02142
MA
Mailing address
101 MAIN STREET
SUITE 1220
CAMBRIDGE
MA
02142
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

53 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-10 10-Q 10-Q 0001193125-26-455376 001-43250 261540134 34 10763330 1 1
2026-11-10 8-K 8-K 2.02,9.01 0001193125-26-454414 001-43250 261537919 34 264161 1 1
2026-11-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002938 005-95667 261529766 34 11794
2026-09-25 4 4 0001193125-26-402936 5489
2026-09-25 3 3 0001193125-26-402904 26050
2026-09-24 8-K 8-K 5.02 0001193125-26-401010 001-43250 261404767 34 145485 1 1
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001388325-26-000046 005-95667 261283530 34 6881
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000902664-26-003462 005-95667 261276608 34 17927
2026-08-12 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001562230-26-000124 005-95667 261265783 34 7616
2026-08-11 10-Q 10-Q 0001193125-26-344533 001-43250 261263020 34 10258167 1 1
2026-08-11 8-K 8-K 2.02,9.01 0001193125-26-343421 001-43250 261260596 34 251327 1 1
2026-08-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002005369-26-000041 005-95667 261251839 34 25167
2026-08-06 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002021 005-95667 261247037 34 11630
2026-08-05 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-090835 005-95667 261241855 34 32712
2026-06-17 4 xslF345X06/form4-06172026_100616.xml 0001231919-26-000665 15348
2026-05-21 4 xslF345X06/form4-05212026_080553.xml 0001231919-26-000521 15346
2026-05-21 10-Q 10-Q 0001193125-26-234386 001-43250 261008256 34 6736905 1 1
2026-05-21 8-K 8-K 2.02,9.01 0001193125-26-233375 001-43250 261005865 34 217972 1 1
2026-05-14 4 xslF345X06/form4-05142026_090553.xml 0001231919-26-000495 13240
2026-05-14 3 3 0001193125-26-223979 26402
2026-05-11 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001346824-26-000127 005-95667 26964752 34 19678
2026-05-11 4 xslF345X06/form4-05112026_090554.xml 0001231919-26-000475 21653
2026-05-11 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-216973 005-95667 26963997 34 695336
2026-05-11 8-K 8-K 5.02 0001193125-26-216699 001-43250 26962989 34 141122 1 1
2026-05-08 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-001639 005-95667 26958644 34 13024
2026-05-06 4 xslF345X06/form4-05062026_110527.xml 0001231919-26-000457 42855
2026-05-06 4 xslF345X06/form4-05062026_080518.xml 0001388325-26-000023 14058
2026-05-04 4 4 0001193125-26-204048 12467
2026-05-04 4 4 0001193125-26-204041 7842
2026-05-04 4 4 0001193125-26-204033 7825
2026-05-04 8-K 8-K 5.03,8.01,9.01 0001193125-26-203988 001-43250 26937633 34 383888 1 1
2026-05-04 S-8 S-8 0001193125-26-201820 333-295513 26934080 33 232416 1 1
2026-05-01 424B4 424B4 0001193125-26-201458 333-294989 26932689 33 6236922
2026-04-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001409 333-294989 26928620 33 1788
2026-04-30 3 xslF345X06/form3-04302026_100448.xml 0001388325-26-000019 8516
2026-04-30 3 xslF345X06/form3-04302026_100424.xml 0001231919-26-000435 21057
2026-04-30 3 3 0001193125-26-198220 32266
2026-04-30 3 3 0001193125-26-198207 29853
2026-04-30 3 3 0001193125-26-198205 28985
2026-04-30 3 3 0001193125-26-198200 31881
2026-04-30 3 3 0001193125-26-198198 27963
2026-04-30 3 3 0001193125-26-198190 28866
2026-04-30 3 3 0001193125-26-198189 28289
2026-04-30 3 3 0001193125-26-198176 32350
2026-04-30 S-1MEF S-1MEF 0001193125-26-197828 333-295466 26927187 33 197857 1 1
2026-04-30 CERT COAG_8A_Cert_2114044.pdf 0001354457-26-000393 001-43250 26923452 34 564698
2026-04-30 S-1/A S-1/A 0001193125-26-193885 333-294989 26919910 33 6486798 1 1
2026-04-28 S-1/A S-1/A 0001193125-26-186964 333-294989 26907727 33 155480
2026-04-27 8-A12B 8-A12B 0001193125-26-181893 001-43250 26900779 34 14299
2026-04-27 S-1/A S-1/A 0001193125-26-178809 333-294989 26896480 33 8473527 1 1
2026-04-10 S-1 S-1 0001193125-26-151378 333-294989 26855445 33 7654652 1 1
2026-04-02 DRS/A filename1.htm 0001193125-26-140464 377-09105 26835185 33 7225018
2026-02-27 DRS filename1.htm 0001193125-26-081986 377-09105 26697551 33 6635898

Latest XBRL company facts

One latest value per concept from companyfacts (113 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 46.73M 2026-10-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
ffd NetFeeAmt NetFeeAmt USD 23,113.83 2026-05-01 S-8 2026-05-04 0001193125-26-201820
ffd TtlFeeAmt TtlFeeAmt USD 23,113.83 2026-05-01 S-8 2026-05-04 0001193125-26-201820
ffd TtlOfferingAmt TtlOfferingAmt USD 167.37M 2026-05-01 S-8 2026-05-04 0001193125-26-201820
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-05-01 S-8 2026-05-04 0001193125-26-201820
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-04-30 S-1MEF 2026-04-30 0001193125-26-197828
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 5.95M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 3.63M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 6.53M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 946,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -2.65M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 687.91M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.16M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap Assets Assets USD 442.71M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap AssetsCurrent Assets, Current USD 438.16M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 202.48M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 4,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 2.65M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 205.13M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 202.48M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 239.15M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 239.15M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 151.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -76.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 26.50M 2025-12-31 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 157.50M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 2.70M 2026-03-31 2026 Q1 10-Q 2026-05-21 0001193125-26-234386
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 223,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.84 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.84 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD -299,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 1.32M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-21 0001193125-26-234386
us-gaap EmployeeBenefitsAndShareBasedCompensationNoncash Employee Benefit and Share-based Payment Arrangement, Noncash USD 5.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 46,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap FinanceLeaseRightOfUseAssetAccumulatedAmortization Finance Lease, Right-of-Use Asset, Accumulated Amortization USD 300,000 2025-12-31 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap ForeignCurrencyTransactionGainLossRealized Foreign Currency Transaction Gain (Loss), Realized USD -200,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap FurnitureAndFixturesGross Furniture and Fixtures, Gross USD 470,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -73.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap IncomeTaxesPaid Income Taxes Paid USD 197,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 802,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 218,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -484,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD 2.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 2.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -17,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD 854,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap InterestIncomeOther Interest Income, Other USD 7.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 9,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 82,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap Liabilities Liabilities USD 13.44M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 442.71M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap LiabilitiesCurrent Liabilities, Current USD 12.94M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap MachineryAndEquipmentGross Machinery and Equipment, Gross USD 887,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 191.09M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 317.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -93.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -72.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -74.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap NetRentableArea Net Rentable Area sqft 4,274 2026-08-31 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap NoncurrentAssets Long-Lived Assets USD 1.41M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap NoninterestExpenseOfferingCost Noninterest Expense Offering Cost USD 29.60M 2026-05-04 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 6.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap OperatingExpenses Operating Expenses USD 79.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -79.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 462,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 503,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 850,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 3.15M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -2.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax USD -1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -2.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 1.20M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -451,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap OtherOperatingIncome Other Operating Income USD 2.96M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-344533
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD -1.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap OtherReceivables Other Receivables USD 1.21M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 29.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 148.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 169,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap PreferredStockConvertibleConversionRatio PreferredStockConvertibleConversionRatio pure 50 2026-03-31 2026 Q1 10-Q 2026-05-21 0001193125-26-234386
us-gaap PreferredStockLiquidationPreferenceValue Preferred Stock, Liquidation Preference, Value USD 349.61M 2025-12-31 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap PreferredStockValueOutstanding Preferred Stock, Value, Outstanding USD 360.17M 2025-12-31 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 7.92M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 6.71M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 317.20M 2026-05-04 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 317.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 40.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 14.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 47,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -74.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 1.50M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 555,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 64.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -256.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 229,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap SalesTypeLeaseSellingProfitLoss Sales-type Lease, Selling Profit (Loss) USD -471,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 15.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 429.27M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 429.27M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 22 2026-04-24 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 26.50M 2026-05-04 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 47,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 317.17M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 26.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 26.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455376

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →